High content drug screening for Fanconi anemia therapeutics | Orphanet Journal of Rare Diseases | Full Text

High content drug screening for Fanconi anemia therapeutics | Orphanet Journal of Rare Diseases | Full Text

High content drug screening for Fanconi anemia therapeutics

Fanconi anemia is a rare disease clinically characterized by malformations, bone marrow failure and an increased risk of solid tumors and hematologic malignancies. The only therapies available are hematopoieti...

Authors:Helena Montanuy, Cristina Camps-Fajol, Jordi Carreras-Puigvert, Maria Häggblad, Bo Lundgren, Miriam Aza-Carmona, Thomas Helleday, Jordi Minguillón and Jordi Surrallés

Citation:Orphanet Journal of Rare Diseases 2020 15:170

Content type:Research

 

Published on: 30 June 2020

• ViewFull Text
 
• ViewPDF